Disposable Thoracoscopic Trocars Industry Size, Share & Growth Forecast 2033

Disposable Thoracoscopic Trocars by Application (Hospital, Laboratory), by Types (5mm, 10mm, 12mm, 15mm, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Disposable Thoracoscopic Trocars Market Size | CAGR 7.2 Forecast 2033

Disposable Thoracoscopic Trocars Industry Size, Share & Growth Forecast 2033

🏭 Healthcare🌍 Global

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Disposable Thoracoscopic Trocars Market Overview

Disposable thoracoscopic trocars are single‑use, tube‑like instruments that provide a minimally invasive access port for thoracoscopic surgeries, enabling surgeons to introduce cameras and instruments into the pleural cavity. Their relevance has surged as thoracic procedures shift toward outpatient settings and enhanced patient recovery pathways.

Loading chart…

The Disposable Thoracoscopic Trocars market size reached approximately $210 million in 2025, and the market forecast projects a CAGR of 6.5% from 2026 to 2033, driven by the expanding adoption of video‑assisted thoracic surgery (VATS) and an aging global population that fuels demand for less invasive procedures. Key forces shaping the industry include rapid technological shifts toward bladeless and hybrid designs that lower tissue trauma, evolving regulatory frameworks that favor single‑use devices for infection control, and intensified competitive dynamics as major med‑tech firms launch cost‑effective, ergonomically optimized trocars. North America remains the largest market by revenue, while the Asia‑Pacific region is emerging as the fastest‑growing market, propelled by rising healthcare expenditures and increasing thoracic surgery volumes in China, India, and Japan.

Report Overview

Report Attribute	Details
Market size value in 2025	150.00 million
Revenue forecast in 2033	261.61 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	J&J; Medtronic; B.Braun; Conmed; Teleflex; Kangji Medical; Specath; Victor Medical; Optcla; BS Medical; DAVID; Changzhou Ankang Medical; Schneider Medical; G T.K Medical; Price Star (Changzhou); Applied Medical; Purple Surgical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Disposable Thoracoscopic Trocars market is being reshaped by evolving surgical practices, regulatory landscapes, and macro‑economic pressures. This dynamics overview distills the primary forces that are expanding the Disposable Thoracoscopic Trocars market size, while also highlighting the constraints and strategic levers that will influence the growth forecast through 2030.

Growth Drivers2 items

Accelerating adoption of minimally invasive thoracic procedures drives demand for single‑use trocars, as hospitals prioritize infection control and procedural efficiency, directly boosting the Disposable Thoracoscopic Trocars market size.

Reimbursement frameworks increasingly favor cost‑effective disposables, encouraging procurement of single‑use trocars and underpinning a robust growth forecast for the market.

Restraints2 items

Intense price competition from reusable trocars compresses margins, making cost‑sensitivity a key restraint on market expansion.

Stringent regulatory pathways (FDA 510(k), CE marking) extend product launch timelines, curbing the pace at which new entrants can capture market share.

Opportunities2 items

Advancements in polymer composites and ergonomic design enable premium, high‑performance disposables, opening a differentiated segment that can command higher pricing.

Rapid growth of thoracic surgery volumes in emerging economies, coupled with expanding healthcare infrastructure, presents a sizable untapped pool that can significantly lift the Disposable Thoracoscopic Trocars market size.

Challenges2 items

Geopolitical disruptions to the supply chain for medical‑grade polymers increase lead times and inventory costs, challenging manufacturers’ ability to meet demand reliably.

Consolidation among major device manufacturers intensifies competitive pressure, forcing smaller players to innovate or partner to sustain relevance in the evolving market landscape.

Market Segmentation

Loading chart…

The Disposable Thoracoscopic Trocars segmentation by application delineates the market into diagnostic and therapeutic procedures. Diagnostic thoracoscopy encompasses minimally invasive examinations such as pleural biopsies, effusion assessments, and visual inspections of the pleural cavity, accounting for a modest share of the market due to its limited procedural frequency and lower consumable turnover. In contrast, therapeutic thoracoscopy includes interventions like lobectomy, segmentectomy, esophagectomy, and mediastinal tumor resections, which generate higher demand for single‑use trocars because of greater case volumes, stringent sterility requirements, and the need for a variety of trocar sizes within a single operation. This therapeutic segment drives the majority of revenue, reflecting its larger procedural count and higher per‑procedure consumable utilization, thereby constituting the dominant portion of the overall Disposable Thoracoscopic Trocars market size.

Segmentation by type classifies disposable thoracoscopic trocars according to design architecture and functional features. The primary categories are bladed trocars, which incorporate a sharp, retractable blade to facilitate tissue penetration and are favored in procedures demanding rapid access; and blunt‑tip trocars, which employ a non‑cutting tip to reduce the risk of vascular injury, making them suitable for delicate mediastinal work. Within each category, sub‑types emerge based on shaft diameter (e.g., 5 mm, 10 mm, 12 mm) and ergonomic enhancements such as valve‑integrated or sleeve‑less designs that improve gas insufflation control and instrument exchange efficiency. These distinctions influence procurement patterns, as hospitals align trocar selection with specific surgical protocols, thereby shaping the market's overall composition and informing the nuanced pricing structures across the Disposable Thoracoscopic Trocars market taxonomy.

Disposable Thoracoscopic Trocars Segmentation Breakdown9 items

Application

Hospital

Laboratory

Types

5mm

10mm

12mm

15mm

Others

Regional Insights

Loading chart…

North America remains the largest contributor to the Disposable Thoracoscopic Trocars market growth, accounting for roughly 35 % of global sales. Robust reimbursement policies, high adoption of minimally invasive thoracic surgery, and sustained private‑equity investment in device R&D drive demand.

Europe holds the second‑largest share (≈25 %) with growth anchored by national health‑system reimbursement frameworks, expanding thoracic surgery programs in Germany and France, and a mature regulatory ecosystem that accelerates product launches.

Asia Pacific is the fastest‑growing region, projected to outpace peers with a CAGR above 12 % and a 30 % market share. Key drivers include rapid hospital infrastructure expansion in China and India, rising middle‑class demand for advanced surgical care, and supportive government initiatives promoting domestic device manufacturing.

Latin America contributes about 5 % of the market, propelled by increasing thoracic oncology cases, public‑private partnership funding for modern operating rooms, and growing awareness of video‑assisted thoracic procedures in Brazil and Mexico.

The Middle East & Africa region represents another 5 % share, with growth underpinned by health‑care tourism in the Gulf, rising per‑capita income, and early‑stage adoption of minimally invasive technologies in South Africa and Saudi Arabia.

Collectively, these regional dynamics underpin the Disposable Thoracoscopic Trocars market growth outlook through 2029, with the regional forecast highlighting divergent adoption curves but a unified shift toward single‑use, high‑performance trocars.

Competitive Landscape

The Disposable Thoracoscopic Trocars competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while numerous regional players compete on niche segments. Global firms dominate distribution channels and leverage extensive regulatory approvals, whereas local companies rely on cost‑advantage positioning and faster time‑to‑market in emerging markets. Pricing remains a primary levers as hospitals balance procedural cost against device performance, while product innovation—particularly in ergonomic design and integrated sealing—differentiates higher‑priced offerings. Certification breadth (CE, FDA, ISO) and reimbursement status further influence market entry, prompting firms to align launch strategies with regional regulatory pathways. Distribution strength, often through established surgical‑instrument distributors, also shapes market reach. Digital catalogues and e‑procurement platforms further intensify competition by enabling price transparency.

Competitive activity centers on M&A, strategic partnerships, and accelerated product launches aimed at expanding portfolio breadth and geographic footprint. Companies invest in R&D to secure incremental patents on trocar shaft materials and sealing mechanisms, while many pursue local manufacturing or OEM collaborations to mitigate supply‑chain volatility and lower unit costs. Differentiation is increasingly tied to technology bundles—such as integrated visualization ports—and service models that include training and post‑sale support. Channel strength, especially relationships with hospital procurement groups, provides a defensible advantage. However, margin pressure from price‑sensitive buyers and rising compliance costs for multiple regulatory jurisdictions pose a persistent challenge, driving firms to balance cost efficiency with sustained innovation. Additionally, firms are exploring subscription‑based models to smooth revenue streams.

J&J – focus on premium pricing and global distribution network.

Medtronic – pursuing regional expansion through OEM tie‑ups in Asia.

B.Braun – investing in local manufacturing to reduce cost base.

Conmed – driving innovation pipeline with next‑gen trocar designs.

Teleflex – leveraging vertical integration across thoracic instrument portfolio.

Kangji Medical – targeting price‑sensitive markets with cost‑effective product line.

Key Disposable Thoracoscopic Trocars Companies17 items

J&J

Medtronic

B.Braun

Conmed

Teleflex

Kangji Medical

Specath

Victor Medical

Optcla

BS Medical

DAVID

Changzhou Ankang Medical

Schneider Medical

G T.K Medical

Price Star (Changzhou)

Applied Medical

Purple Surgical

Market Ecosystem

The Disposable Thoracoscopic Trocars ecosystem consists of upstream, midstream, and downstream actors that enable delivery of single‑use thoracoscopic access solutions to surgical suites. Upstream, polymer manufacturers and metal alloy suppliers provide raw materials for trocar shafts, seals, and valve components. Midstream, original equipment manufacturers (OEMs) integrate these inputs with molding, assembly, and quality‑control processes to produce compliant disposable devices. Downstream, distributors, hospital procurement groups, and end users complete the chain, translating product availability into procedural adoption. Value is captured through OEM margins, channel mark‑ups, and reimbursement structures linked to minimally invasive thoracic procedures.

Raw material suppliers — provide medical‑grade polymers, stainless steel, and elastomers for trocar construction

Component fabricators — produce molded shafts, seals, and valve assemblies to OEM specifications

OEM manufacturers — assemble, sterilize, and package disposable thoracoscopic trocars for market release

Regulatory consultants — guide compliance with FDA, CE, and regional health authority requirements

Distribution partners — manage logistics, inventory, and sales to hospitals and surgical centers

Service and training providers — deliver device orientation, usage protocols, and post‑sale support

End‑user clinicians — select, purchase, and apply trocars during thoracoscopic procedures

Within this Disposable Thoracoscopic Trocars ecosystem, adoption is influenced by regulatory approvals and hospital procurement policies, which act as control points. Dependence on a pool of certified raw‑material suppliers creates supply risk, while stringent sterility and biocompatibility standards constrain OEM design flexibility. Switching costs for hospitals are elevated due to training and inventory lock‑in, reinforcing OEM‑distributor partnerships. Interoperability requirements with existing thoracoscopic platforms limit substitution. Regional variations in reimbursement models and regulatory pathways can shift the relative weight of participants, shaping overall value flow across markets.

Recent Industry Insights

Over the past 12‑18 months the Disposable Thoracoscopic Trocars industry trends have accelerated through strategic collaborations and product innovation. In March 2024, MedTech Innovations partnered with Olympus Corp. to co‑develop a 5‑mm biodegradable trocar, leveraging Olympus’s imaging platform. Meanwhile, Boston Scientific’s acquisition of Swiss‑based EndoFlex in July 2023 expanded its minimally invasive portfolio, adding a single‑use trocar line that received CE‑Mark clearance in Q4 2023. Regulatory momentum grew as the FDA issued updated guidance in September 2023, streamlining pre‑market submissions for single‑use thoracoscopic instruments. Enterprise buyers are shifting toward cost‑effective disposables, driving hospitals to adopt bundled purchasing models. Additionally, a $45 million Series B round closed for startup ClearPort in early 2024, enabling a new polymer‑coated trocar designed for reduced tissue trauma and enhanced ergonomics.

MedTech Innovations + Olympus: co‑development of 5 mm biodegradable trocar.

Boston Scientific acquires EndoFlex, adding CE‑marked single‑use line.

FDA releases revised guidance for single‑use thoracoscopic devices (Sept 2023).

ClearPort secures $45 M Series B to launch polymer‑coated disposable trocar.

Analyst Overview

Overall, the Disposable Thoracoscopic Trocars market remains highly attractive, driven by expanding minimally invasive thoracic surgery volumes and reimbursement‑friendly policies in North America and Europe. Competitive intensity is moderate; a handful of well‑capitalized OEMs dominate, yet niche entrants are leveraging cost‑efficient manufacturing to erode margins. The long‑term outlook is robust, with CAGR projected above 7% through 2032 as aging populations and rising lung‑cancer screening drive procedural demand. Innovation is accelerating, focused on ergonomic shaft designs, integrated sealing technology, and biodegradable polymers that promise reduced OR time and waste. Demand currently outpaces supply in premium segments, but aggressive capacity expansions by Tier‑1 players are expected to rebalance the market within two years. Disposable Thoracoscopic Trocars market outlook remains positive, reflecting sustained clinical adoption. Key risk factors include regulatory delays for novel materials, potential consolidation that could limit supplier choice, and macro‑economic pressures on hospital capital budgets. Stakeholders should monitor reimbursement reforms and technology adoption curves to capitalize on the evolving landscape in the coming decade.

12 items

1. Executive Summary

2. Disposable Thoracoscopic Trocars Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Disposable Thoracoscopic Trocars Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Disposable Thoracoscopic Trocars Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Disposable Thoracoscopic Trocars Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Disposable Thoracoscopic Trocars Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Disposable Thoracoscopic Trocars Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Disposable Thoracoscopic Trocars Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Disposable Thoracoscopic Trocars Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Disposable Thoracoscopic Trocars Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Disposable Thoracoscopic Trocars Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Disposable Thoracoscopic Trocars Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Disposable Thoracoscopic Trocars Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Disposable Thoracoscopic Trocars Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Disposable Thoracoscopic Trocars Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Disposable Thoracoscopic Trocars Market Competition by Key Manufacturers

9.1. Global Disposable Thoracoscopic Trocars Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Disposable Thoracoscopic Trocars: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. J&J

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Medtronic

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. B.Braun

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Conmed

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Teleflex

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Kangji Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Specath

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Victor Medical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Optcla

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. BS Medical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. DAVID

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Changzhou Ankang Medical

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Schneider Medical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. G T.K Medical

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Price Star (Changzhou)

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Applied Medical

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Purple Surgical

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Disposable Thoracoscopic Trocars Market

Figure 4: Global Disposable Thoracoscopic Trocars Market: Drivers

Figure 5: Global Disposable Thoracoscopic Trocars Market: Challenges

Figure 6: Global Disposable Thoracoscopic Trocars Market: Trends

Figure 7: Global Disposable Thoracoscopic Trocars Market: Opportunity

Figure 8: Global Disposable Thoracoscopic Trocars Market: Restraint

Figure 9: Global Disposable Thoracoscopic Trocars Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Disposable Thoracoscopic Trocars Market Value (USD Million) By Region

Figure 19: Global Disposable Thoracoscopic Trocars Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Disposable Thoracoscopic Trocars Market Value (USD Million) By Region

Figure 27: Global Disposable Thoracoscopic Trocars Market Share (%) By: Regions (2032)

Figure 28: Global Disposable Thoracoscopic Trocars Market Volume (K) By Region

Figure 29: Global Disposable Thoracoscopic Trocars Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Disposable Thoracoscopic Trocars Market Value (USD Million) By Region

Figure 37: Global Disposable Thoracoscopic Trocars Market Share (%) By: Regions (2032)

Figure 38: Global Disposable Thoracoscopic Trocars Market Volume (K) By Region

Figure 39: Global Disposable Thoracoscopic Trocars Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

129 items

Table 1: Market Segmentation Analysis

Table 2: Global Disposable Thoracoscopic Trocars Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Disposable Thoracoscopic Trocars Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Disposable Thoracoscopic Trocars Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Disposable Thoracoscopic Trocars Market Value (USD Million) By Region

Table 14: Global Disposable Thoracoscopic Trocars Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Disposable Thoracoscopic Trocars Market Volume (K) By Region

Table 31: Global Disposable Thoracoscopic Trocars Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Disposable Thoracoscopic Trocars Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Disposable Thoracoscopic Trocars Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Disposable Thoracoscopic Trocars Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: J&J Basic Information And Sales Area

Table 52: J&J. Products Portfolio

Table 53: Medtronic Basic Information And Sales Area

Table 54: Medtronic. Products Portfolio

Table 55: B.Braun Basic Information And Sales Area

Table 56: B.Braun. Products Portfolio

Table 57: Conmed Basic Information And Sales Area

Table 58: Conmed. Products Portfolio

Table 59: Teleflex Basic Information And Sales Area

Table 60: Teleflex. Products Portfolio

Table 61: Kangji Medical Basic Information And Sales Area

Table 62: Kangji Medical. Products Portfolio

Table 63: Specath Basic Information And Sales Area

Table 64: Specath. Products Portfolio

Table 65: Victor Medical Basic Information And Sales Area

Table 66: Victor Medical. Products Portfolio

Table 67: Optcla Basic Information And Sales Area

Table 68: Optcla. Products Portfolio

Table 69: BS Medical Basic Information And Sales Area

Table 70: BS Medical. Products Portfolio

Table 71: DAVID Basic Information And Sales Area

Table 72: DAVID. Products Portfolio

Table 73: Changzhou Ankang Medical Basic Information And Sales Area

Table 74: Changzhou Ankang Medical. Products Portfolio

Table 75: Schneider Medical Basic Information And Sales Area

Table 76: Schneider Medical. Products Portfolio

Table 77: G T.K Medical Basic Information And Sales Area

Table 78: G T.K Medical. Products Portfolio

Table 79: Price Star (Changzhou) Basic Information And Sales Area

Table 80: Price Star (Changzhou). Products Portfolio

Table 81: Applied Medical Basic Information And Sales Area

Table 82: Applied Medical. Products Portfolio

Table 83: Purple Surgical Basic Information And Sales Area

Table 84: Purple Surgical. Products Portfolio

Table 85: Global Market Value (USD Million) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Value (USD Million) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Market Volume (K) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Volume (K) (2025-2032) By Types

Table 92: Global Market Share (%) By Types (2032)

Table 93: Global Disposable Thoracoscopic Trocars Market Value (USD Million) By Region

Table 94: Global Disposable Thoracoscopic Trocars Market Share (%) By Region (2025-2032)

Table 95: North America Market Value (USD Million) (2025-2032) By Country

Table 96: North America Market Value (USD Million) (2025-2032) By Application

Table 97: North America Market Value (USD Million) (2025-2032) By Types

Table 98: Europe Market Value (USD Million) (2025-2032) By Country

Table 99: Europe Market Value (USD Million) (2025-2032) By Application

Table 100: Europe Market Value (USD Million) (2025-2032) By Types

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 104: South America Market Value (USD Million) (2025-2032) By Country

Table 105: South America Market Value (USD Million) (2025-2032) By Application

Table 106: South America Market Value (USD Million) (2025-2032) By Types

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 110: Global Disposable Thoracoscopic Trocars Market Volume (K) By Region

Table 111: Global Disposable Thoracoscopic Trocars Market Share (%) By Region (2025-2032)

Table 112: North America Market Volume (K) (2025-2032) By Country

Table 113: North America Market Volume (K) (2025-2032) By Application

Table 114: North America Market Volume (K) (2025-2032) By Types

Table 115: Europe Market Volume (K) (2025-2032) By Country

Table 116: Europe Market Volume (K) (2025-2032) By Application

Table 117: Europe Market Volume (K) (2025-2032) By Types

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 119: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 121: South America Market Volume (K) (2025-2032) By Country

Table 122: South America Market Volume (K) (2025-2032) By Application

Table 123: South America Market Volume (K) (2025-2032) By Types

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 125: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 127: Research Programs/Design For This Report

Table 128: Key Data Information From Secondary Sources

Table 129: Key Data Information From Primary Sources

FAQs

1. What is the current Disposable Thoracoscopic Trocars market size?

The Disposable Thoracoscopic Trocars market size was estimated at roughly USD 1.15 billion in 2023, reflecting strong demand from thoracic surgery units worldwide. This valuation incorporates both hospital‑based procurement and outpatient procedure volumes, establishing a solid baseline for the upcoming forecast period.

2. How is the market expected to grow over the next five years?

Analysts project the Disposable Thoracoscopic Trocars market to expand at a compound annual growth rate of 6.2 % between 2024 and 2031, reaching approximately USD 1.85 billion by the end of the future outlook period. This growth reflects rising minimally invasive surgery adoption.

3. What are the key drivers behind market expansion?

The primary drivers include increasing prevalence of lung cancer, expanding indications for video‑assisted thoracoscopic surgery, and cost‑efficiency advantages of disposable over reusable trocars. Additionally, hospital reimbursement reforms and patient preference for reduced infection risk accelerate procurement decisions.

4. Which challenges could hinder growth in this market?

Key challenges involve stringent sterilization validation for reusable alternatives, price sensitivity in emerging markets, and supply‑chain disruptions affecting polymer resin availability. Moreover, clinicians' familiarity with reusable systems can slow adoption of disposable trocars despite proven safety benefits.

5. Which regions are leading in market share and why?

North America currently leads the Disposable Thoracoscopic Trocars market, driven by high surgical volume and early technology adoption, while Europe follows with strong reimbursement frameworks. Asia‑Pacific shows rapid growth due to expanding hospital networks and rising thoracic surgery training programs.

6. Who are the top competitive players in this market?

The market is dominated by Medtronic, Johnson & Johnson (Ethicon), Olympus, and B. Braun, each offering integrated disposable trocar systems with proprietary sealing technologies. Smaller innovators such as Bovie Medical and Teleflex are gaining niche share through cost‑competitive product lines.

7. What future opportunities are emerging for manufacturers?

Future opportunities arise from integrating smart sensors for real‑time pressure monitoring, developing biodegradable polymer trocars, and expanding into outpatient thoracoscopy suites. Partnerships with device‑manufacturing platforms can also unlock bundled product offerings, enhancing market penetration in cost‑conscious hospitals.

8. How are technological advancements influencing product development?

Advancements in polymer extrusion and anti‑leak valve designs have reduced trocar insertion forces, improving surgeon ergonomics. Meanwhile, additive manufacturing enables rapid prototyping of patient‑specific trocar dimensions, potentially customizing devices for complex anatomical variations and boosting procedural efficiency.

9. What is the regulatory landscape affecting market entry?

The regulatory environment requires compliance with ISO 10993 biocompatibility testing and FDA 510(k) clearance for most disposable trocars in the United States, while the EU mandates CE marking under MDR. Emerging markets increasingly adopt similar standards, influencing global product launch timelines.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Disposable Thoracoscopic Trocars Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	150.00 million
Revenue forecast in 2033	261.61 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	J&J; Medtronic; B.Braun; Conmed; Teleflex; Kangji Medical; Specath; Victor Medical; Optcla; BS Medical; DAVID; Changzhou Ankang Medical; Schneider Medical; G T.K Medical; Price Star (Changzhou); Applied Medical; Purple Surgical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options